Vir Biotechnology (VIR) Stock Statistics & Valuation Metrics

Vir Biotechnology has a market cap or net worth of $706.40M. The enterprise value is $2.64B.

Vir Biotechnology has 138,238,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Vir Biotechnology’s return on equity (ROE) is -0.45 and return on invested capital (ROIC) is -45.53%.

The current PE Ratio of Vir Biotechnology is -1.92. Vir Biotechnology’s PEG ratio is -1.47.

In the last 12 months, Vir Biotechnology had revenue of 74.20M and earned -521.96M in profits. Earnings per share was -3.83.

In the last 12 months, operating cash flow was -415.08M and capital expenditures -7.06M, giving a free cash flow of -422.14M billion.

Vir Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―

Vir Biotechnology upcoming earnings date is Jul 31, 2025, After Close (Confirmed).

Vir Biotechnology as a current ratio of 8.71, with Debt / Equity ratio of 6.16%

In the past 12 months, Vir Biotechnology has paid -1.15M in taxes.

Vir Biotechnology EV to EBITDA ratio is -1.46, with an EV/FCF ratio of -1.73.

Vir Biotechnology has $801.66M in cash and marketable securities with $96.09M in debt, giving a net cash position of -$705.57M billion.

Gross margin is 90.74%, with operating margin of -791.27%, and net profit margin of -703.40%.

The average price target for Vir Biotechnology is $18.14, which is 11.43% higher than the current price. The consensus rating is Strong Buy